This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Clinicopathologic factors and survival in patients with sebaceous carcinoma of eyelid

Clinicopathologic factors and survival in patients with sebaceous carcinoma of eyelid
Reviewed by Rina Bhatt

5 February 2020 | Rina Bhatt | EYE - Oculoplastic, EYE - Orbit

This is a population-based analysis performed to evaluate the prognostic factors and survival of patients with sebaceous carcinoma of the eyelid. Patients with eyelid sebaceous carcinoma from 1973-2013 were identified from the Surveillance, Epidemiology and End Results (SEER) database and data regarding patient age, year of diagnosis, sex, race, laterality, treatment modality, tumour size, tumour extent, lymph node involvement, and tumour grade was extracted. The SEER database collects and publishes cancer incidence and survival outcome data from population-based cancer registries in the United States. The majority (84.6%) were treated with surgery, 1% with radiation only, 4.6% with both surgery and radiation, and 8% with neither surgery nor radiation. Precise tumour size was unknown in 68.4% and regional and distal metastasis were found in 13.2% and 1.9% respectively. Histologically, the tumour was graded as well, moderately or poorly differentiated, however, grade was unknown in 65.1%. There was an increasing trend per decade from 1973, however, it is not known whether this is due to increasing reporting. Overall survival derived from Kaplan-Meier analysis was 66% and 44% at five and 10 years respectively. There was no statistical significant difference with the grade of tumour and overall survival though histological grade of tumour was unknown in 65.1%. Survival varied with treatment modality. Patients who received surgical treatment only showed higher median overall survival (10.3 years) compared to radiation only (3.0 years) and combined surgery and radiation (6.1 years). Overall survival varied with tumour size; shorter survival for tumours more than 20mm in size. However, tumour size was unknown in more than half of patients. Similarly, patients with lymph node involvement had shorter overall survival than one without.

Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid – a population-based analysis.
Lee IJ, Koh JY.
ORBIT
2019;38:261-8.
Share This
CONTRIBUTOR
Rina Bhatt

Wolverhampton Eye Infirmary, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency